Archives in Cancer Research

  • ISSN: 2254-6081
  • Journal h-index: 11
  • Journal CiteScore: 0.91
  • Journal Impact Factor: 0.6
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Blue Faery helps liver cancer patients spread their wings

2nd International Conference on Cancer Science & Pediatrics
February 19-20, 2019 | Prague, Czech Republic

Andrea J Wilson

Blue Faery: The Adrienne Wilson Liver Cancer Association, USA

Keynote: Arch Cancer Res


According to the European Respiratory Society, patient advocacy organizations serve three roles: support and advise others; make changes happen and provide the patient’s perspective. Blue Faery is the only non-profit corporation in the United States that specifically devoted to fighting primary liver cancer, especially Hepatocellular Carcinoma (HCC), the second most common cause of cancer deaths worldwide. Blue Faery’s mission is to prevent, treat and cure primary liver cancer through research, education and advocacy. Blue Faery has five key values that drive the organization: commitment to outstanding service to patients and caregivers; competence with high quality products; cost effectiveness and efficiency; conscientious collaboration and communication and transparency. These values ensure that the organization always puts its end users i.e. patients and caregivers above funders. Blue Faery supports and advises patients and caregivers through its educational materials, online community, one-onone peer support program and website that translates into nine languages specifically targeted at the HCC patient population. As a member of the Deadliest Cancers Coalition (DCC), Blue Faery works with other non-profits to make changes happen at the federal level. Most recently, the efforts of the DCC resulted in $2 billion increase for the National Institutes of Health (NIH) for FY2019. Blue Faery works with its partners in a number of ways to provide the patient’s perspective. From online surveys to in-person meetings, Blue Faery brings HCC patients, caregivers and survivors together to facilitate discussions about improving outcomes and increasing access to clinical trials. When patient advocacy groups serve patients and caregivers, they can make a major impact on the quality of life for patients and caregivers as well as on the visibility, funding, research and awareness of the disease.

Biography :

Andrea J Wilson founded Blue Faery: The Adrienne Wilson Liver Cancer Association after losing her 15-year-old sister Adrienne, whom she raised for seven years, to stage IV liver cancer. Blue Faery’s mission is to prevent, treat and cure primary liver cancer, specifically hepatocellular carcinoma (HCC), through research, education and advocacy. As a patient advocate, Andrea serves on many committees and advisory boards including the NCI She Hepatobiliary Task Force and Target Pharma Solutions HCC Advisory Board. is the only American to serve on CCSN’s Liver Cancer Advisory Council. Andrea represents Blue Faery as a member of AASLD, ASCO, Deadliest Cancers Coalition, GI Cancers Alliance, etc. Andrea’s goal is to see a cure for HCC in her lifetime.

E-mail: [email protected]